These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 26268138
1. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Neurocrit Care; 2016 Feb; 24(1):132-9. PubMed ID: 26268138 [Abstract] [Full Text] [Related]
2. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Sheth KN, Elm JJ, Molyneaux BJ, Hinson H, Beslow LA, Sze GK, Ostwaldt AC, Del Zoppo GJ, Simard JM, Jacobson S, Kimberly WT. Lancet Neurol; 2016 Oct; 15(11):1160-9. PubMed ID: 27567243 [Abstract] [Full Text] [Related]
3. Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Sheth KN, Kimberly WT, Elm JJ, Kent TA, Yoo AJ, Thomalla G, Campbell B, Donnan GA, Davis SM, Albers GW, Jacobson S, del Zoppo G, Simard JM, Stern BJ, Mandava P. Neurocrit Care; 2014 Aug; 21(1):43-51. PubMed ID: 24671831 [Abstract] [Full Text] [Related]
6. Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide. Hinson HE, Sun E, Molyneaux BJ, von Kummer R, Demchuk A, Romero J, Taylor Kimberly W, Sheth KN. J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104916. PubMed ID: 32414580 [Abstract] [Full Text] [Related]
16. Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction. Vorasayan P, Bevers MB, Beslow LA, Sze G, Molyneaux BJ, Hinson HE, Simard JM, von Kummer R, Sheth KN, Kimberly WT. Stroke; 2019 Nov 01; 50(11):3021-3027. PubMed ID: 31537189 [Abstract] [Full Text] [Related]
17. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ, Wintermark M, American Heart Association Stroke Council. Stroke; 2014 Apr 01; 45(4):1222-38. PubMed ID: 24481970 [Abstract] [Full Text] [Related]
18. [Follow-up monitoring with magnetic resonance tomography after decompressive trephining in experimental "malignant" hemispheric infarct]. Engelhorn T, Dörfler A, Egelhof T, Schwab S, Heiland S, Sartor K, Forsting M. Zentralbl Neurochir; 1998 Apr 01; 59(3):157-65. PubMed ID: 9816666 [Abstract] [Full Text] [Related]
19. Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients. Armahizer MJ, Howard AK, Seung H, Kalasapudi L, Sansur C, Morris NA. World Neurosurg; 2021 Mar 01; 147():e63-e68. PubMed ID: 33253952 [Abstract] [Full Text] [Related]
20. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus. Jain R, Osei K, Kupfer S, Perez AT, Zhang J. Pharmacotherapy; 2006 Oct 01; 26(10):1388-95. PubMed ID: 16999648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]